2017 EFPIA Disclosure Report on Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organizations
Astellas is a member company of the European Federation of Pharmaceutical Industries and Associations (“EFPIA”) and adheres to the EFPIA Disclosure Code 2014 (the “EFPIA Disclosure Code”).
The EFPIA Disclosure Code requires all member companies to document and disclose certain Transfers of Value they make, directly or indirectly, to or for the benefit of, Healthcare Professionals (“HCPs”) or Healthcare Organisations (“HCOs”) (“Disclosures”).
The EFPIA Disclosure Code is implemented in Italy by Farmindustria - Association of pharmaceutical companies - member of Confindustria. Astellas discloses all Transfers of Value to HCPs and HCOs in accordance with its commitment to the EFPIA Disclosure Code and any applicable Italian national code.
Astellas Pharma SpA - Via Del Bosco Rinnovato, 6 Palazzo U7, 20090 Assago (MI)
C.F. 04754860155 / P. IVA 00789580966 - Registro delle Imprese di Milano REA n° 1035548
Capitale Sociale euro 20.252.904,00 i.v.
Controllata da Astellas Pharma Europe Ltd.
- > 2017 EFPIA Disclosure Report on Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organizations